Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve Un-audited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arunjyoti Bio Ventures Ltd (Scrip Code: 530881) has informed BSE that its Board of Directors will meet on Tuesday, 3 February 2026 at the registered office in Hyderabad. The key item on the agenda is to consider and approve the un-audited financial results along with the Limited Review Report for the quarter ended 31 December 2025 (Q3 FY26). The notice also includes the standard 'any other business with the permission of the Chair' clause. The intimation is signed by Whole-Time Director Pabbathi Badari Narayana Murthy.
This is a routine pre-results intimation required under listing rules. No actual financial numbers are disclosed here, so there is no direct impact on shareholders until the Q3 results are published on or after 3 February 2026.